Aveanna Healthcare Holdings, Inc.
Financial highlights
| Metric | FY January 3, 2026 | FY December 28, 2024 | FY December 30, 2023 | FY December 31, 2022 | FY January 1, 2022 |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.0B | $1.9B | $1.8B | $1.7B |
| Gross profit | $810.5M | $635.5M | $595.4M | $553.2M | $542.4M |
| Operating income | $256.5M | $139.8M | $8.1M | -$642.3M | -$36.1M |
| Cash from operations | $125.9M | $32.6M | $22.7M | -$48.4M | -$11.3M |
| Capital expenditure | — | — | — | — | $15.9M |
| Free cash flow | — | — | — | — | -$27.3M |
| Impairments | — | $0 | $105.1M | $675.3M | $117.7M |
| Total assets | $2.0B | $1.7B | $1.6B | $1.7B | $2.3B |
| Total liabilities | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B |
| Total debt | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
Shares outstanding 217.8M · Free float 43.7%
Annual filing data through FY ended January 3, 2026; float as of June 27, 2026.